| Product Code: ETC099500 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The United States (US) Gastrointestinal devices Market was estimated at USD 256 Million in 2025 and is projected to reach USD 344 Million by 2032, growing at a CAGR of 4.3% from 2026 to 2032. This growth trajectory is driven by an aging population increasingly susceptible to gastrointestinal disorders, alongside advancements in minimally invasive procedures and innovative device technologies. Additionally, the rising prevalence of conditions such as colorectal cancer and inflammatory bowel disease is further propelling demand for effective diagnostic and therapeutic options in this market.
This graph highlights how the United States (US) Gastrointestinal devices Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 0.7% | Technological integration in medical devices streamlined gastrointestinal diagnostics production |
| 2022 | 7.1% | Export driven demand for gastrointestinal devices spurred local manufacturing investments |
| 2023 | 4.6% | Advanced manufacturing technologies boost production efficiency in gastrointestinal devices |
| 2024 | 4.8% | Export driven demand surge boosted gastrointestinal device manufacturing capacity |
| 2025 | 5.1% | Regional healthcare facility upgrades boosted gastrointestinal device production需求 |
| 2026 | 5.0% | Medical device companies upgrade facilities to boost gastrointestinal device production |
| 2027 | 5.0% | Export driven demand boosts production capacity for gastrointestinal devices |
| 2028 | 5.4% | Regional hospital expansions boosted demand for gastrointestinal device manufacturing |
| 2029 | 5.8% | Export driven demand for innovative surgical instruments boosts production capacity |
| 2030 | 5.5% | Regional healthcare facilities upgraded gastrointestinal device technology integration efforts |
| 2031 | 6.0% | Gastrointestinal device manufacturers prioritize advanced manufacturing technology investments |
| 2032 | 6.0% | Telehealth integration boosted demand for remote patient monitoring devices |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The most significant force shaping the US gastrointestinal devices market is the escalating demand for minimally invasive surgical techniques. These techniques not only enhance patient outcomes but also reduce hospital stays, which appeals to both healthcare providers and patients alike.
Additionally, the integration of advanced technologies such as digital monitoring and smart pill systems is gaining momentum. These innovations are enabling earlier detection and treatment of gastrointestinal diseases, subsequently fostering a more proactive approach to digestive health management.
Despite its potential, the US gastrointestinal devices market faces several constraints that could impede growth. Chief among these are the stringent regulatory approval processes required for new devices, which can significantly delay time-to-market. Moreover, the high costs associated with research and development can be a substantial barrier, particularly for smaller firms that may lack the necessary capital. These challenges compel companies to invest heavily in compliance and innovation, making it difficult to navigate the competitive landscape effectively.
The US gastrointestinal devices market is currently experiencing a notable trend towards the adoption of advanced endoscopic techniques. Devices such as capsule endoscopes and endoscopic ultrasound systems are on the rise, driven by the need for less invasive diagnostic methods. Furthermore, the integration of digital solutions, such as remote patient monitoring and data analytics, is enhancing treatment efficacy and patient engagement. The market is also witnessing a focus on developing devices that emphasize cost-effectiveness and value-based care, aiming to meet the dual demands of healthcare providers and patients.
There are substantial investment opportunities within the US gastrointestinal devices market, particularly in the realms of diagnostic and therapeutic endoscopic devices. Given the rise in minimally invasive procedures, sectors such as stenting and enteral feeding are poised for growth. Companies that prioritize innovation and forge strategic alliances with healthcare institutions will be well-positioned to capitalize on emerging trends and patient needs. Additionally, investments in the development of smart devices and telehealth solutions could yield significant returns as healthcare continues to evolve.
Government policies governing the US gastrointestinal devices market are focused primarily on ensuring patient safety and the efficacy of medical products. The Food and Drug Administration (FDA) plays a pivotal role, enforcing stringent premarket approval processes that require comprehensive safety and effectiveness data from manufacturers. Additionally, reimbursement policies from programs such as Medicare are critical in determining market accessibility and financial viability, thereby influencing the adoption of new devices across healthcare settings.
Looking forward to the period from 2026 to 2032, the United States gastrointestinal devices market is anticipated to maintain a steady growth trajectory. The increasing incidence of gastrointestinal disorders and an aging population will likely continue to drive demand. Furthermore, ongoing technological advancements in device design and functionality are expected to enhance therapeutic options, making them more effective and patient-friendly. Companies committed to innovation and quality will be central to the market's evolution as they respond to the healthcare sector's shifting needs.
Recent developments in the US gastrointestinal devices market indicate a growing emphasis on innovation and patient-centered design. Companies are increasingly launching advanced devices that integrate smart technologies and data analytics capabilities. Additionally, partnerships between device manufacturers and healthcare providers are expanding, aimed at enhancing treatment modalities and improving patient outcomes. This evolving landscape reflects a commitment to addressing the pressing needs of healthcare systems and patients alike.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Gastrointestinal devices Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Gastrointestinal devices Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Gastrointestinal devices Market - Industry Life Cycle |
3.4 United States (US) Gastrointestinal devices Market - Porter's Five Forces |
3.5 United States (US) Gastrointestinal devices Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 United States (US) Gastrointestinal devices Market Revenues & Volume Share, By Sales channel, 2022 & 2032F |
3.7 United States (US) Gastrointestinal devices Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 United States (US) Gastrointestinal devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal disorders in the US population |
4.2.2 Advancements in technology leading to the development of innovative gastrointestinal devices |
4.2.3 Rising adoption of minimally invasive procedures for gastrointestinal treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of gastrointestinal devices |
4.3.2 High cost associated with gastrointestinal devices impacting affordability |
4.3.3 Limited reimbursement policies for certain gastrointestinal procedures |
5 United States (US) Gastrointestinal devices Market Trends |
6 United States (US) Gastrointestinal devices Market, By Types |
6.1 United States (US) Gastrointestinal devices Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Gastrointestinal devices Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 United States (US) Gastrointestinal devices Market Revenues & Volume, By GI Videoscopes, 2022-2032F |
6.1.4 United States (US) Gastrointestinal devices Market Revenues & Volume, By Biopsy Devices, 2022-2032F |
6.1.5 United States (US) Gastrointestinal devices Market Revenues & Volume, By Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), 2022-2032F |
6.1.6 United States (US) Gastrointestinal devices Market Revenues & Volume, By Capsule Endoscopy, 2022-2032F |
6.1.7 United States (US) Gastrointestinal devices Market Revenues & Volume, By Endoscopic Ultrasound, 2022-2032F |
6.1.8 United States (US) Gastrointestinal devices Market Revenues & Volume, By Endoscopic Mucosal Resection (EMR), 2022-2032F |
6.1.9 United States (US) Gastrointestinal devices Market Revenues & Volume, By Others, 2022-2032F |
6.1.10 United States (US) Gastrointestinal devices Market Revenues & Volume, By Others, 2022-2032F |
6.2 United States (US) Gastrointestinal devices Market, By Sales channel |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Gastrointestinal devices Market Revenues & Volume, By Online Retailing, 2022-2032F |
6.2.3 United States (US) Gastrointestinal devices Market Revenues & Volume, By Medical Stores & Brand Outlet, 2022-2032F |
6.3 United States (US) Gastrointestinal devices Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Gastrointestinal devices Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.3 United States (US) Gastrointestinal devices Market Revenues & Volume, By Clinics & Dialysis Centers, 2022-2032F |
6.3.4 United States (US) Gastrointestinal devices Market Revenues & Volume, By Ambulatory Surgical Center, 2022-2032F |
6.3.5 United States (US) Gastrointestinal devices Market Revenues & Volume, By Others, 2022-2032F |
7 United States (US) Gastrointestinal devices Market Import-Export Trade Statistics |
7.1 United States (US) Gastrointestinal devices Market Export to Major Countries |
7.2 United States (US) Gastrointestinal devices Market Imports from Major Countries |
8 United States (US) Gastrointestinal devices Market Key Performance Indicators |
8.1 Number of FDA approvals for new gastrointestinal devices |
8.2 Rate of adoption of minimally invasive gastrointestinal procedures |
8.3 Investment in research and development for gastrointestinal devices |
8.4 Patient satisfaction and outcomes post gastrointestinal device procedures |
8.5 Utilization rate of gastrointestinal devices in healthcare facilities |
9 United States (US) Gastrointestinal devices Market - Opportunity Assessment |
9.1 United States (US) Gastrointestinal devices Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 United States (US) Gastrointestinal devices Market Opportunity Assessment, By Sales channel, 2022 & 2032F |
9.3 United States (US) Gastrointestinal devices Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 United States (US) Gastrointestinal devices Market - Competitive Landscape |
10.1 United States (US) Gastrointestinal devices Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Gastrointestinal devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here